Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
3.170
-0.010 (-0.31%)
At close: Apr 1, 2025, 4:00 PM
3.219
+0.049 (1.54%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Corvus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2163448640112100
Upgrade
Market Cap Growth
298.31%298.31%118.11%-64.73%12.29%-37.55%
Upgrade
Enterprise Value
16530256-74051
Upgrade
Last Close Price
3.175.351.760.852.413.56
Upgrade
PB Ratio
6.6110.562.230.711.161.39
Upgrade
P/TBV Ratio
10.5610.562.230.711.161.39
Upgrade
Debt / Equity Ratio
0.030.030.040.050.040.03
Upgrade
Quick Ratio
1.471.473.963.997.223.65
Upgrade
Current Ratio
1.541.544.074.067.363.73
Upgrade
Return on Equity (ROE)
-174.85%-174.85%-57.02%-53.90%-51.08%-8.37%
Upgrade
Return on Assets (ROA)
-30.09%-30.09%-25.63%-22.50%-24.61%-32.33%
Upgrade
Return on Capital (ROIC)
-46.69%-46.69%-29.52%-25.06%-27.38%-36.77%
Upgrade
Earnings Yield
-28.84%-18.12%-31.32%-104.39%-38.55%-6.00%
Upgrade
FCF Yield
-11.77%-7.40%-27.77%-68.97%-32.73%-34.89%
Upgrade
Buyback Yield / Dilution
-26.99%-26.99%-3.16%-11.23%-41.98%-0.44%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q